SANOFINSESanofi India Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 5 Jan · 15:55 IST

Sanofi India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the period ended 31st December 2025.

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sanofi India has submitted to the stock exchanges a compliance certificate from its Registrar and Share Transfer Agent (RTA), MUFG Intime India Private Limited, for the quarter ended 31st December 2025. The certificate is filed under SEBI's Regulation 74(5), which relates to the dematerialisation of shares. The RTA confirms that all share certificates received from depository participants for dematerialisation during the quarter were processed (accepted or rejected) and the underlying securities have been listed on the stock exchanges. It also confirms that physical certificates received were mutilated and cancelled, and the depository's name was substituted as the registered owner in the company's member register within the prescribed timelines.

Likely market impact

This is a routine quarterly compliance filing with no material impact on the business, financials, or share price. It simply confirms the orderly processing of dematerialisation requests during the October–December 2025 quarter and is required by SEBI regulation.